These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6439999)

  • 1. Fulminant hepatitis. Mayo Clinic experience with 34 cases.
    Rakela J; Ludwig J; Baldus WP
    Minn Med; 1984 Dec; 67(12):671-2. PubMed ID: 6439999
    [No Abstract]   [Full Text] [Related]  

  • 2. [Halothane hepatitis. Possibilities of prevention].
    Døssing M; Andreasen B; Ranek L; Johansen SH
    Ugeskr Laeger; 1982 Feb; 144(7):466-8. PubMed ID: 7080249
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of drug-induced hepatic complications collected by the French drug surveillance organization].
    Jean-Pastor MJ; Jouglard J
    Therapie; 1984; 39(5):493-500. PubMed ID: 6506005
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigations into an outbreak of hepatitis in parts of western India.
    Krishnamachari KA; Bhat RV; Nagarajan V; Tilak TB
    Indian J Med Res; 1975 Jul; 63(7):1036-49. PubMed ID: 1213790
    [No Abstract]   [Full Text] [Related]  

  • 5. Aetiology of fatal viral hepatitis in Melbourne. A retrospective study.
    McNeil M; Hoy JF; Richards MJ; Lehmann NI; Dimitrikakis M; Gust ID; Lucas CR
    Med J Aust; 1984 Nov; 141(10):637-40. PubMed ID: 6436653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the Centers for Disease Control and Prevention. Severe isoniazid-associated hepatitis--New York, 1991-1993.
    JAMA; 1993 Aug; 270(7):809. PubMed ID: 8340970
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing trends in hepatitis C-related mortality in the United States, 1995-2004.
    Wise M; Bialek S; Finelli L; Bell BP; Sorvillo F
    Hepatology; 2008 Apr; 47(4):1128-35. PubMed ID: 18318441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of death and characteristics of decedents with viral hepatitis, United States, 2010.
    Ly KN; Xing J; Klevens RM; Jiles RB; Holmberg SD
    Clin Infect Dis; 2014 Jan; 58(1):40-9. PubMed ID: 24065331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halothane hepatitis: a critical review.
    Carney FM; Van Dyke RA
    Anesth Analg; 1972; 51(1):135-60. PubMed ID: 4399967
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe isoniazid-associated hepatitis--New York, 1991-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jul; 42(28):545-7. PubMed ID: 8326947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected].
    Galan MV; Potts JA; Silverman AL; Gordon SC
    J Clin Gastroenterol; 2005 Jan; 39(1):64-7. PubMed ID: 15599214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C in Poland in 2006].
    Bobel D; Rosińska M
    Przegl Epidemiol; 2008; 62(2):325-32. PubMed ID: 18807475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of acute hepatitis among outpatients in the urban community of Lyon, 1983].
    Chossegros P; Chevallier P; Trepo C; Sepetjan M
    Rev Epidemiol Sante Publique; 1986; 34(3):174-80. PubMed ID: 3786875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid preventive therapy: Retrospect and prospect.
    Dash LA; Comstock GW; Flynn JP
    Am Rev Respir Dis; 1980 Jun; 121(6):1039-44. PubMed ID: 7416591
    [No Abstract]   [Full Text] [Related]  

  • 16. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chloramphenicol-hepatitis-aplastic anemia syndrome].
    Shibata A; Fukuda M
    Nihon Rinsho; 1977; 35 Suppl 1():970-1. PubMed ID: 613075
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon treatment in acute progressive and fulminant hepatitis.
    Levin S; Leibowitz E; Torten J; Hahn T
    Isr J Med Sci; 1989 Jul; 25(7):364-72. PubMed ID: 2474521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term extra-corporeal assistance by continuous haemofiltration during fulminant hepatic failure.
    Denis J; Opolon P; Delorme ML; Granger A; Darnis F
    Gastroenterol Clin Biol; 1979 Apr; 3(4):337-47. PubMed ID: 499696
    [No Abstract]   [Full Text] [Related]  

  • 20. [HGV is rare but possible causative agent of non-A non-B fulminant hepatitis].
    Ishikawa K; Hasegawa K; Hayashi N
    Nihon Rinsho; 1997 Mar; 55(3):621-4. PubMed ID: 9086770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.